Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
|Articles|September 1, 2010
Missouri Welcomes Soybean Innovation
Advertisement
In partnership with the State of Missouri, Soy Labs LLC (Fairfield, CA) broke ground on the Missouri Plant Science Center in Mexico. The center will serve as a biotechnology hub for companies such as Soy Labs to research novel manufacturing processes for soybeans and other plant-based materials for the nutraceuticals, functional foods, and plant biotechnology industries.
Partly funded by the Missouri Department of Economic Development, the center will be a shared-use facility. It includes office space, wet- and dry-research laboratories, and manufacturing equipment. Soy Labs is in charge of managing the 25,000-sq-ft facility. The company will also recruit other firms to participate in the project.
Advertisement
Related to this article
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Study of SRI-81 Shatavari Reports Sexual Function Gains Versus Placebo in Women
2
Thirty Years of GCP: The Evolution From Study Execution to Evidence Generation
3
Navigating Supplement Ingredients and Claims Regulations in Europe, the US, and Canada
4
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
5